Key result
Disproportionate tricuspid regurgitation linked to ~2.1-fold higher mortality under medical management.
Why the study?
The concept of a regurgitant lesion disproportionate to ventricular size has been studied for prognosis in functional mitral regurgitation, but its definition and prognostic role had not been explored in tricuspid regurgitation.
Does disproportionate tricuspid regurgitation (AROA/RVEDVi ratio >0.74 on cardiac CT) predict worse survival compared to proportionate tricuspid regurgitation in patients with severe tricuspid regurgitation?
Cohort (n=174)
Does disproportionate tricuspid regurgitation (AROA/RVEDVi ratio >0.74 on cardiac CT) predict worse survival compared to proportionate tricuspid regurgitation in patients with severe tricuspid regurgitation?
Cardiac CT-based assessment of the anatomical regurgitant orifice area to right ventricular end-diastolic volume ratio identifies a subset of severe tricuspid regurgitation patients with disproportionate regurgitation who face a more than two-fold higher risk of mortality under medical management.
Disproportionate TR by CT ratio identifies higher mortality risk under medical management; extends mitral regurgitation concept to tricuspid valve but leaves prospective validation open.
Background The concept of a disproportionate regurgitant lesion compared to the ventricular size has been widely investigated for prognostic purposes in functional mitral regurgitation patients. However, it has never been explored in the context of tricuspid regurgitation (TR) so far. Purpose To define and assess the prognostic role of disproportionate TR compared to right ventricular (RV) volumes in a cohort of severe TR patients evaluated by cardiac computed tomography (CCT). Methods Comprehensive clinical, echocardiographic and CCT data were collected from consecutive severe TR patients who had CCT measurements of both RV volumes and tricuspid valve anatomical regurgitant orifice area (AROA), a novel CCT parameter to quantify TR which we recently associated with outcome1 (Figure 1, panel A). The AROA/RV end-diastolic volumes indexed (RVEDVi) ratio was used to assess the relationship between proportionate/disproportionate TR with the outcome of interest, which was all-cause under medical management. Results We included 174 patients (median age 83 years, median RV ejection fraction 46%). Spline curve analysis showed that increasing values of AROA/RVEDVi ratio associated with progressive risk of outcome occurrence, and the prognostic cut-off associated with hazard ratio (HR) >1 was >0.74 (Figur 1, panel B1). Baseline characteristics were not significant for age, Euroscore II and biventricular ejection fraction (EF), but patients with high AROA/RVEDVi (disproportionate TR) had higher pulmonary artery systolic pressure, larger tricuspid reg. volumes and worse CCT-derived RV free-wall longitudinal strain compared to patients with low AROA/RVEDVi (proportionate TR, all p-values <0.05). After a median follow-up of 2.3 years, patients with disproportionate TR had significantly worse survival (Figure 1, panel B2), univariably and after multivariable analysis in two models adjusted for both clinical characteristics (adjusted HR 2.11, 95% confidence interval 1.19-3.75, p-value =0.01) and imaging variables (adjusted HR 2.01, 95% confidence interval 1.11-3.66, p-value =0.02). Exploratory secondary analysis for the 43 patients (24%) treated with transcatheter edge-to-edge repair (T-TEER), showed that disproportionate TR patients had similar achievements of TR reduction >2+ grades compared to those with proportionate TR (72% vs 63%, p-value= 0.210), despite larger median maximum coaptation gap (7 vs 11 mm, p-value<0.001). Conclusions CCT-based assessment of AROA/RVEDV ratio identifies a higher mortality risk cohort in which TR severity becomes disproportionate to RV remodeling. Larger studies are necessary to confirm our hypothesis that prognostic impact of TR severity is modulated by the degree of RV remodeling.
No takes yet. Share an insight, caveat, or question.
Margonato et al. (2026) conducted a cohort in Severe tricuspid regurgitation (n=174). Disproportionate tricuspid regurgitation (AROA/RVEDVi > 0.74) vs. Proportionate tricuspid regurgitation (low AROA/RVEDVi) was evaluated on All-cause mortality under medical management (HR 2.11, 95% CI 1.19-3.75, p=0.01). Disproportionate tricuspid regurgitation (AROA/RVEDVi >0.74) was associated with worse survival under medical management (adjusted HR 2.11; 95% CI 1.19-3.75; p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: